Global Influenza Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 101

Published Date: 25 May 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Influenza Vaccine market size is estimated to be worth US$ 7819.9 million in 2021 and is forecast to a readjusted size of USD 11060 million by 2028 with a CAGR of 5.1% during forecast period 2022-2028. 6 Months to 3 Years accounting for % of the Influenza Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Trivalent Influenza Vaccine segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Influenza Vaccine include Sanofi, CSL, GSK, Viatris, and AstraZeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Influenza Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine

Market segment by Application can be divided into
    6 Months to 3 Years
    > 3 Years

The key market players for global Influenza Vaccine market are listed below:
    Sanofi
    CSL
    GSK
    Viatris
    AstraZeneca
    Hualan Bio
    Changchun Institute of Biological
    Sinovac
    BCHT
    Jiangsu GDK
    KM Biologics

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenza Vaccine, with price, sales, revenue and global market share of Influenza Vaccine from 2019 to 2022.
Chapter 3, the Influenza Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Vaccine.
Chapter 13, 14, and 15, to describe Influenza Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Influenza Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Influenza Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Trivalent Influenza Vaccine
        1.2.3 Quadrivalent Influenza Vaccine
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Influenza Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 6 Months to 3 Years
        1.3.3 > 3 Years
    1.4 Global Influenza Vaccine Market Size & Forecast
        1.4.1 Global Influenza Vaccine Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Influenza Vaccine Sales in Volume (2017-2028)
        1.4.3 Global Influenza Vaccine Price (2017-2028)
    1.5 Global Influenza Vaccine Production Capacity Analysis
        1.5.1 Global Influenza Vaccine Total Production Capacity (2017-2028)
        1.5.2 Global Influenza Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Influenza Vaccine Market Drivers
        1.6.2 Influenza Vaccine Market Restraints
        1.6.3 Influenza Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Influenza Vaccine Product and Services
        2.1.4 Sanofi Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 CSL
        2.2.1 CSL Details
        2.2.2 CSL Major Business
        2.2.3 CSL Influenza Vaccine Product and Services
        2.2.4 CSL Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 GSK
        2.3.1 GSK Details
        2.3.2 GSK Major Business
        2.3.3 GSK Influenza Vaccine Product and Services
        2.3.4 GSK Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Viatris
        2.4.1 Viatris Details
        2.4.2 Viatris Major Business
        2.4.3 Viatris Influenza Vaccine Product and Services
        2.4.4 Viatris Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 AstraZeneca
        2.5.1 AstraZeneca Details
        2.5.2 AstraZeneca Major Business
        2.5.3 AstraZeneca Influenza Vaccine Product and Services
        2.5.4 AstraZeneca Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Hualan Bio
        2.6.1 Hualan Bio Details
        2.6.2 Hualan Bio Major Business
        2.6.3 Hualan Bio Influenza Vaccine Product and Services
        2.6.4 Hualan Bio Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Changchun Institute of Biological
        2.7.1 Changchun Institute of Biological Details
        2.7.2 Changchun Institute of Biological Major Business
        2.7.3 Changchun Institute of Biological Influenza Vaccine Product and Services
        2.7.4 Changchun Institute of Biological Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Sinovac
        2.8.1 Sinovac Details
        2.8.2 Sinovac Major Business
        2.8.3 Sinovac Influenza Vaccine Product and Services
        2.8.4 Sinovac Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 BCHT
        2.9.1 BCHT Details
        2.9.2 BCHT Major Business
        2.9.3 BCHT Influenza Vaccine Product and Services
        2.9.4 BCHT Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Jiangsu GDK
        2.10.1 Jiangsu GDK Details
        2.10.2 Jiangsu GDK Major Business
        2.10.3 Jiangsu GDK Influenza Vaccine Product and Services
        2.10.4 Jiangsu GDK Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 KM Biologics
        2.11.1 KM Biologics Details
        2.11.2 KM Biologics Major Business
        2.11.3 KM Biologics Influenza Vaccine Product and Services
        2.11.4 KM Biologics Influenza Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Influenza Vaccine Breakdown Data by Manufacturer
    3.1 Global Influenza Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Influenza Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Influenza Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Influenza Vaccine Manufacturer Market Share in 2021
        3.4.2 Top 6 Influenza Vaccine Manufacturer Market Share in 2021
    3.5 Global Influenza Vaccine Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Influenza Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Influenza Vaccine Market Size by Region
        4.1.1 Global Influenza Vaccine Sales in Volume by Region (2017-2028)
        4.1.2 Global Influenza Vaccine Revenue by Region (2017-2028)
    4.2 North America Influenza Vaccine Revenue (2017-2028)
    4.3 Europe Influenza Vaccine Revenue (2017-2028)
    4.4 Asia-Pacific Influenza Vaccine Revenue (2017-2028)
    4.5 South America Influenza Vaccine Revenue (2017-2028)
    4.6 Middle East and Africa Influenza Vaccine Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Influenza Vaccine Sales in Volume by Type (2017-2028)
    5.2 Global Influenza Vaccine Revenue by Type (2017-2028)
    5.3 Global Influenza Vaccine Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Influenza Vaccine Sales in Volume by Application (2017-2028)
    6.2 Global Influenza Vaccine Revenue by Application (2017-2028)
    6.3 Global Influenza Vaccine Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Influenza Vaccine Sales by Type (2017-2028)
    7.2 North America Influenza Vaccine Sales by Application (2017-2028)
    7.3 North America Influenza Vaccine Market Size by Country
        7.3.1 North America Influenza Vaccine Sales in Volume by Country (2017-2028)
        7.3.2 North America Influenza Vaccine Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Influenza Vaccine Sales by Type (2017-2028)
    8.2 Europe Influenza Vaccine Sales by Application (2017-2028)
    8.3 Europe Influenza Vaccine Market Size by Country
        8.3.1 Europe Influenza Vaccine Sales in Volume by Country (2017-2028)
        8.3.2 Europe Influenza Vaccine Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Influenza Vaccine Sales by Type (2017-2028)
    9.2 Asia-Pacific Influenza Vaccine Sales by Application (2017-2028)
    9.3 Asia-Pacific Influenza Vaccine Market Size by Region
        9.3.1 Asia-Pacific Influenza Vaccine Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Influenza Vaccine Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Influenza Vaccine Sales by Type (2017-2028)
    10.2 South America Influenza Vaccine Sales by Application (2017-2028)
    10.3 South America Influenza Vaccine Market Size by Country
        10.3.1 South America Influenza Vaccine Sales in Volume by Country (2017-2028)
        10.3.2 South America Influenza Vaccine Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Influenza Vaccine Sales by Type (2017-2028)
    11.2 Middle East & Africa Influenza Vaccine Sales by Application (2017-2028)
    11.3 Middle East & Africa Influenza Vaccine Market Size by Country
        11.3.1 Middle East & Africa Influenza Vaccine Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Influenza Vaccine Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Influenza Vaccine and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Influenza Vaccine
    12.3 Influenza Vaccine Production Process
    12.4 Influenza Vaccine Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Influenza Vaccine Typical Distributors
    13.3 Influenza Vaccine Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Influenza Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Influenza Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Influenza Vaccine Product and Services
    Table 6. Sanofi Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. CSL Basic Information, Manufacturing Base and Competitors
    Table 8. CSL Major Business
    Table 9. CSL Influenza Vaccine Product and Services
    Table 10. CSL Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. GSK Basic Information, Manufacturing Base and Competitors
    Table 12. GSK Major Business
    Table 13. GSK Influenza Vaccine Product and Services
    Table 14. GSK Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Viatris Basic Information, Manufacturing Base and Competitors
    Table 16. Viatris Major Business
    Table 17. Viatris Influenza Vaccine Product and Services
    Table 18. Viatris Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 20. AstraZeneca Major Business
    Table 21. AstraZeneca Influenza Vaccine Product and Services
    Table 22. AstraZeneca Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 24. Hualan Bio Major Business
    Table 25. Hualan Bio Influenza Vaccine Product and Services
    Table 26. Hualan Bio Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 28. Changchun Institute of Biological Major Business
    Table 29. Changchun Institute of Biological Influenza Vaccine Product and Services
    Table 30. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 32. Sinovac Major Business
    Table 33. Sinovac Influenza Vaccine Product and Services
    Table 34. Sinovac Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. BCHT Basic Information, Manufacturing Base and Competitors
    Table 36. BCHT Major Business
    Table 37. BCHT Influenza Vaccine Product and Services
    Table 38. BCHT Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 40. Jiangsu GDK Major Business
    Table 41. Jiangsu GDK Influenza Vaccine Product and Services
    Table 42. Jiangsu GDK Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 44. KM Biologics Major Business
    Table 45. KM Biologics Influenza Vaccine Product and Services
    Table 46. KM Biologics Influenza Vaccine Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. Global Influenza Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
    Table 48. Global Influenza Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 49. Market Position of Manufacturers in Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 50. Global Influenza Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
    Table 51. Head Office and Influenza Vaccine Production Site of Key Manufacturer
    Table 52. Influenza Vaccine New Entrant and Capacity Expansion Plans
    Table 53. Influenza Vaccine Mergers & Acquisitions in the Past Five Years
    Table 54. Global Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 55. Global Influenza Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 56. Global Influenza Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 57. Global Influenza Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 58. Global Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 59. Global Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 60. Global Influenza Vaccine Revenue by Type (2017-2022) & (USD Million)
    Table 61. Global Influenza Vaccine Revenue by Type (2023-2028) & (USD Million)
    Table 62. Global Influenza Vaccine Price by Type (2017-2022) & (USD/Doses)
    Table 63. Global Influenza Vaccine Price by Type (2023-2028) & (USD/Doses)
    Table 64. Global Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 65. Global Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 66. Global Influenza Vaccine Revenue by Application (2017-2022) & (USD Million)
    Table 67. Global Influenza Vaccine Revenue by Application (2023-2028) & (USD Million)
    Table 68. Global Influenza Vaccine Price by Application (2017-2022) & (USD/Doses)
    Table 69. Global Influenza Vaccine Price by Application (2023-2028) & (USD/Doses)
    Table 70. North America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 71. North America Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 72. North America Influenza Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 73. North America Influenza Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 74. North America Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 75. North America Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 76. North America Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 77. North America Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 78. Europe Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 79. Europe Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 80. Europe Influenza Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 81. Europe Influenza Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 82. Europe Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 83. Europe Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 84. Europe Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 85. Europe Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 86. Asia-Pacific Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 87. Asia-Pacific Influenza Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 88. Asia-Pacific Influenza Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 89. Asia-Pacific Influenza Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 90. Asia-Pacific Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 91. Asia-Pacific Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 92. Asia-Pacific Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 93. Asia-Pacific Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 94. South America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 95. South America Influenza Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 96. South America Influenza Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 97. South America Influenza Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 98. South America Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 99. South America Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 100. South America Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 101. South America Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 102. Middle East & Africa Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 103. Middle East & Africa Influenza Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 104. Middle East & Africa Influenza Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 105. Middle East & Africa Influenza Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 106. Middle East & Africa Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 107. Middle East & Africa Influenza Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 108. Middle East & Africa Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 109. Middle East & Africa Influenza Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 110. Influenza Vaccine Raw Material
    Table 111. Key Manufacturers of Influenza Vaccine Raw Materials
    Table 112. Direct Channel Pros & Cons
    Table 113. Indirect Channel Pros & Cons
    Table 114. Influenza Vaccine Typical Distributors
    Table 115. Influenza Vaccine Typical Customers
List of Figures
    Figure 1. Influenza Vaccine Picture
    Figure 2. Global Influenza Vaccine Revenue Market Share by Type in 2021
    Figure 3. Trivalent Influenza Vaccine
    Figure 4. Quadrivalent Influenza Vaccine
    Figure 5. Global Influenza Vaccine Revenue Market Share by Application in 2021
    Figure 6. 6 Months to 3 Years
    Figure 7. > 3 Years
    Figure 8. Global Influenza Vaccine Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
    Figure 9. Global Influenza Vaccine Revenue and Forecast (2017-2028) & (USD Million)
    Figure 10. Global Influenza Vaccine Sales (2017-2028) & (M Doses)
    Figure 11. Global Influenza Vaccine Price (2017-2028) & (USD/Doses)
    Figure 12. Global Influenza Vaccine Production Capacity (2017-2028) & (M Doses)
    Figure 13. Global Influenza Vaccine Production Capacity by Geographic Region: 2022 VS 2028
    Figure 14. Influenza Vaccine Market Drivers
    Figure 15. Influenza Vaccine Market Restraints
    Figure 16. Influenza Vaccine Market Trends
    Figure 17. Global Influenza Vaccine Sales Market Share by Manufacturer in 2021
    Figure 18. Global Influenza Vaccine Revenue Market Share by Manufacturer in 2021
    Figure 19. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 20. Top 3 Influenza Vaccine Manufacturer (Revenue) Market Share in 2021
    Figure 21. Top 6 Influenza Vaccine Manufacturer (Revenue) Market Share in 2021
    Figure 22. Global Influenza Vaccine Sales Market Share by Region (2017-2028)
    Figure 23. Global Influenza Vaccine Revenue Market Share by Region (2017-2028)
    Figure 24. North America Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 25. Europe Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 26. Asia-Pacific Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 27. South America Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 28. Middle East & Africa Influenza Vaccine Revenue (2017-2028) & (USD Million)
    Figure 29. Global Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 30. Global Influenza Vaccine Revenue Market Share by Type (2017-2028)
    Figure 31. Global Influenza Vaccine Price by Type (2017-2028) & (USD/Doses)
    Figure 32. Global Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 33. Global Influenza Vaccine Revenue Market Share by Application (2017-2028)
    Figure 34. Global Influenza Vaccine Price by Application (2017-2028) & (USD/Doses)
    Figure 35. North America Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 36. North America Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 37. North America Influenza Vaccine Sales Market Share by Country (2017-2028)
    Figure 38. North America Influenza Vaccine Revenue Market Share by Country (2017-2028)
    Figure 39. United States Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 40. Canada Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Mexico Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Europe Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 43. Europe Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 44. Europe Influenza Vaccine Sales Market Share by Country (2017-2028)
    Figure 45. Europe Influenza Vaccine Revenue Market Share by Country (2017-2028)
    Figure 46. Germany Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. France Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. United Kingdom Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Russia Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Italy Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2017-2028)
    Figure 52. Asia-Pacific Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 53. Asia-Pacific Influenza Vaccine Sales Market Share by Region (2017-2028)
    Figure 54. Asia-Pacific Influenza Vaccine Revenue Market Share by Region (2017-2028)
    Figure 55. China Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Japan Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Korea Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. India Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Southeast Asia Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Australia Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. South America Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 62. South America Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 63. South America Influenza Vaccine Sales Market Share by Country (2017-2028)
    Figure 64. South America Influenza Vaccine Revenue Market Share by Country (2017-2028)
    Figure 65. Brazil Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Argentina Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2017-2028)
    Figure 68. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2017-2028)
    Figure 69. Middle East & Africa Influenza Vaccine Sales Market Share by Region (2017-2028)
    Figure 70. Middle East & Africa Influenza Vaccine Revenue Market Share by Region (2017-2028)
    Figure 71. Turkey Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Egypt Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Saudi Arabia Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. South Africa Influenza Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Manufacturing Cost Structure Analysis of Influenza Vaccine in 2021
    Figure 76. Manufacturing Process Analysis of Influenza Vaccine
    Figure 77. Influenza Vaccine Industrial Chain
    Figure 78. Sales Channel: Direct Channel vs Indirect Channel
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Related Reports

Global Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Influenza Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 05 Jun 2021

date Pharma & Healthcare

The Influenza Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Oct 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Influenza Vaccine market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.

Global Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Global Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

date 18 Oct 2023

date Pharma & Healthcare

The global Influenza Vaccine market size is expected to reach $ 11570 million by 2029, rising at a market growth of 5.3% CAGR during the forecast period (2023-2029).

Product Tags

influenza vaccine

flu influenza vaccine

pandemic influenza vaccine

nasal spray influenza vaccine

children influenza vaccine

canine influenza vaccine

equine influenza vaccine

needle free influenza vaccine

inhaled nasal influenza vaccine

inactivated influenza vaccine

injection influenza vaccine

live attenuated influenza vaccine laiv

trivalent inactivated influenza vaccine

Needle-Free Influenza Vaccine

Flu (Influenza) Vaccine

Nasal Spray Live Attenuated Influenza Vaccine

Live Attenuated Influenza Vaccine (LAIV)

Split Influenza Vaccine

Adjuvanted Influenza Vaccine

Recombinant Influenza Vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>